Damià Tormo, CEO of Columbus Venture Partners and winner of the Rei Jaume I Prize for Business Revelation 2025, received a visit from Javier Quesada, executive president of the Rei Jaume I Prizes Foundation in Valencia, and representatives of the award’s collaborating entities: Marta Coscollar, Director of Business Relations and Entrepreneurship at EDEM Business School, and Diego Lorente, Secretary General and Director of the Valencian Business Association (AVE).

During the visit, Damià highlighted that we are currently experiencing a period of significant change in the fields of health and biotechnology, many of them are being driven by artificial intelligence. According to the winner, ‘In five years, we will witness a transformation of humanity, and therefore, of our social paradigm. Significant advances in medicine, biology and engineering will undoubtedly bring about momentous changes for human beings. For example, people will live much longer thanks to the early diagnosis of diseases and anti-ageing therapies.”

Damià made these statements during a visit by the collaborators of the Business Revelation Prize, where this year’s winner explained his work and his transition from biology to business.

According to Damiá, “developing the most common skin cancer therapy was one of our first scientific and bioindustrial successes, but it has not been the only one. We have created a dozen companies dedicated to combating different diseases, some of which are ultra-rare. The Columbus Venture Partners foundation has done what is truly important in the latter: providing access to treatment for those who cannot afford it.”

He also spoke about two major projects: the largest biotechnology center being built in San Sebastián and the creation of the future Institute of Longevity in the Valencian Community.

The jury valued his role as an entrepreneur who serves as a catalyst for many other projects, promoting quality jobs, attracting foreign investment, and positioning Spain as an international benchmark. “His business work is characterized by a focus on improving people’s health and quality of life. In addition, Damià Tormo demonstrates a social commitment that he develops through his philanthropic work, helping, among other things, in the treatment of children with rare diseases,” said the jury.

Last June at their traditional Jury Meeting, the jurors of the 37th edition of the Rei Jaume I Prizes announced the seven winners in the different categories: Basic Research, Economics, Biomedical Research, Environmental Protection, New Technologies, Entrepreneurial Revelation, and Clinical Research and Public Health.

This year, the jury for the prizes was made up of nearly a hundred people, 20 of whom are Nobel laureates in different disciplines. In addition, as every year, the jury included the country’s leading businessmen and women, as every year in the Entrepreneur jury.

The Business Revelation Prize is supported by Mercadona, EDEM Business School, and AVE. In this edition, the jury for this category recognized Damià Tormo with this prize from among more than 50 nominees for his clearly entrepreneurial profile, as he began his first business venture at a very young age. His experience has enabled him to create Columbus Venture Partners, an entity that builds bridges between scientific research and the real arrival of solutions to society, especially to patients suffering from serious illnesses. This has led him to found a dozen companies based on research projects that have made it possible to introduce these scientific innovations to the market and enable people to benefit from them. In total, this has led to the creation of more than 1,000 jobs, attracted 400€ million in investment, and generated more than 5.000€ million in returns.